Zelmic is a proven and reliable CRO / CDMO partner combining regulatory and scientific knowledge in a fast, flexible and quality-focused organization. Our experts in semisolids are focused entirely on topical formulations and drug delivery and can lead you through the entire development process. We are located in Lund, Sweden, one of the top science hubs in Europe conveniently connected with Copenhagen and Stockholm, and home to numerous life science companies.
About UsTurn your ideas into effective topical drug products by taking advantage of our fast, cost-efficient, risk mitigating and GMP approved services. These range from formulation development, stability testing, analytical method development and validation, to In-Vitro Release Testing (IVRT), In-Vitro Skin Permeation Testing (IVPT) and IMP GMP Manufacturing.
PRODUCT
DEVELOPMENT
IMP GMP
Manufacture
ANALYTICAL
CHEMISTRY
PERFORMANCE
TESTING
In the development of topical drug formulations, one of the greatest challenges is ensuring that in vitro (laboratory-based) tests accurately reflect how a drug will behave in vivo (on human skin). This is where In Vitro-In Vivo Correlation (IVIVC) plays a crucial role. A strong IVIVC allows pharmaceutical developers to predict drug absorption, efficacy, and…
Continue Reading
Center for Translational Research AB (CTR) expands by acquiring Zelmic AB, the GMP-approved Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), specialized in development of topical and transdermal pharmaceutical formulations and drug delivery. The acquisition further expands CTRs portfolio, within pharmaceutical, regulatory, and clinical development to the CTR group.
Continue Reading